Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.75 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | CDC25B | P30305 | 1/20 | 0.55 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31472931 | 1.00 | GPR3 (0.75) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL29368441 | 1.00 | GPR3 (0.75) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL29481 | 0.86 | GPR3 (1.00) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL29387122 | 0.86 | GPR3 (1.00) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL10945035 | 0.82 | MAOA (0.57) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL17954672 | 0.82 | MAOA (0.54) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL12796758 | 0.82 | CHEK1 (0.59) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL16900704 | 0.82 | MEN1 (0.62) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL5972625 | 0.82 | GPR3 (0.52) | GPR3CHEK1MEN1KMT2AL3MBTL1 | |
| SCHEMBL5800591 | 0.82 | CHEK1 (0.59) | GPR3CHEK1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112010847-A | Solution-processable organic electroluminescent diode main body material and application thereof | 南京工业职业技术大学 | 2020-12-01 | — | — | CN | claimed |
| US-20200227664-A1 | ELECTROLUMINESCENT DEVICE AND LIGHT-EMITTING LAYER AND APPLICATION THEREOF | GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-07-16 | — | — | US | claimed |
| EP-3247773-B1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC COMPONENTS | CYNORA GMBH (DE) | 2019-10-02 | — | — | EP | claimed |
| US-20140357633-A1 | COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2014-12-04 | — | — | US | claimed |
| EP-2794592-A1 | COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS | Novartis AG (CH) | 2014-10-29 | — | — | EP | claimed |
| WO-2013096060-A1 | COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS | NOVARTIS AG (CH) | 2013-06-27 | — | — | WO | claimed |
| US-8367745-B2 | Includes alkaline earth metal oxide as acidity neutralization stabilizer; quick setting, mechanical strength; repairing prosthesis | GC CORPORATION (JP) | 2013-02-05 | — | — | US | claimed |
| US-7678843-B2 | Dental restorative material composition | GC CORPORATION (JP) | 2010-03-16 | — | — | US | claimed |
| US-5770638-A | CONSISTS OF TETRAHYDROFURFURYL METHACRYLATE, ONE OR MORE METHACRYLATE HAVING ATLEAST ONE DOUBLE BOND SELECTED FROM DI-2-METHACRYLOXYETHYL-2,2-4-TRIMETHYLHEXAMETHYLENE DICARBAMATE AND OTHER ACRYLATED CARBAMATE AND PHOTOINITIATORS | GC CORPORATION (JP) | 1998-06-23 | — | — | US | claimed |
| JP-10168427-A | — | — | None | — | — | JP | disclosed |
| JP-62034980-A | — | — | None | — | — | JP | disclosed |
| JP-10168427-A | — | — | None | — | — | JP | disclosed |
| CN-122080034-A | Polycyclic aromatic compound and organic electroluminescent element | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122059973-A | Polycyclic aromatic compound, material for organic device, organic electroluminescent element, display device, and lighting device | 爱思开新材料捷恩智株式会社 | 2026-05-19 | — | — | CN | disclosed |
| US-4377579-A | ANTIALLERGENS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-03-22 | — | — | US | disclosed |
| US-4177257-A | ANTIANAPHYLACTIC AGENTS | BURROUGHS WELLCOME CO. (US) | 1979-12-04 | — | — | US | disclosed |
| US-4145350-A | ANTIALLERGENS, TETRAZOLYL- SUBSTITUTED | BURROUGHS WELLCOME CO. (US) | 1979-03-20 | — | — | US | disclosed |
| US-4103015-A | TRICYCLIC THIOXANTHONE-10,10-DIOXIDES | BURROUGHS WELLCOME CO. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4103015-A | TRICYCLIC THIOXANTHONE-10,10-DIOXIDES | BURROUGHS WELLCOME CO. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4012499-A | USED IN THE RELIEF AND PROPHYLAXIS OF ALLERGIC CONDITIONS | BURROUGHS WELLCOME CO. (US) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357633-A1 | COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS | BCL2, BCL2A1, BCL2L1 | GPR3 2272/4885CHEK1 1450/4885MEN1 2831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.